Adult data demonstrates better glucose control with less hypoglycemia on basal-bolus regimens using the previously discussed rapid-acting analogs with newer long-acting insulin analogs compared to NPH insulin/regular human insulin [52,53]. This evidence concerns the gene INS and Hypoglycemia.